The DOI matches its Crossref record.
Effect of Aldosterone and Glycyrrhetinic Acid on the Protein Expression of PAI-1 and p22phox in Human Mononuclear Leukocytes
Open accessAbstract
Aldosterone excess can produce heart and kidney fibrosis, which seem to be related to a direct effect of aldosterone at the level of specific receptors. We report a direct, mineralocorticoid-mediated effect on the protein expression of two markers of oxidative stress after incubation of mononuclear leukocytes with 1 × 10−8m aldosterone (p22phox/β-actin = 1.38 ± 0.05 and PAI-1/β-actin = 1.80 ± 0.05). The same effect was also found with 3 × 10−5m glycyrrhetinic acid, the principal constituent of licorice root (p22phox/β-actin = 1.37 ± 0.97 and PAI-1/β-actin = 1.80 ± 0.04). The effect of both aldosterone and glycyrrhetinic acid is blocked by incubation with added 1 × 10−6m of receptor-antagonist canrenone. Canrenone alone did not show any effect. PAI-1 related protein was also found using 4 × 10−9m aldosterone. Incubations with 1 × 10−9m for 3 hours as well as 1 × 10−8m aldosterone for 5, 10, and 20 minutes were ineffective for both proteins. These data support the previous finding of an involvement of mononuclear leukocytes in the pathogenesis of the oxidative stress induced by hyperaldosteronism. In addition, the results confirm our previous data on a direct effect of glycyrrhetinic acid at the level of mineralocorticoid receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“subsequent studies confirmed that the incubation of lymphocytes with excess aldosterone increased the protein expression of PAI 1 and p22phox, two markers of inflammation [16].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Batiha, G. E., Beshbishy, A. M., El‐Mleeh, A., Abdel‐Daim, M. M., & Devkota, H. P. (2020) · Biomolecules · doi:10.3390/biom10030352 · Cited by 488
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis
Brown, N. J. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.110 · Cited by 464
Armanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
Self-citationAldosterone and end-organ damage
Brown, N. J. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000165889.60254.98 · Cited by 321
Rickard, A. J., Morgan, J., Tesch, G. H., Funder, J. W., Fuller, P. J., & Young, M. J. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.131110 · Cited by 315
Muñoz‐Durango, N., Fuentes, C., Castillo, A., González-Gómez, L. M., Vecchiola, A., Fardella, C., & Kalergis, A. M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17070797 · Cited by 297
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
Barrera‐Chimal, J., Girerd, S., & Jaisser, F. (2019) · Kidney International · doi:10.1016/j.kint.2019.02.030 · Cited by 267
Aldosterone and Vascular Inflammation
Brown, N. J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.095489 · Cited by 259
Licorice abuse: time to send a warning message
Omar, H., Komarova, I., Elghonemi, M., Fathy, A., Rashad, R., Abdelmalak, H. D., Yerramadha, M. R., Ali, Y., Helal, E., & Camporesi, E. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812454322 · Cited by 239
Aldosterone and end-organ damage
Marney, A. M., & Brown, N. J. (2007) · Clinical Science · doi:10.1042/cs20070123 · Cited by 234
The Cooperative Roles of Inflammation and Oxidative Stress in the Pathogenesis of Hypertension
Crowley, S. D. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5258 · Cited by 196
Gilbert, K. C., & Brown, N. J. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283391989 · Cited by 164
Non-genomic actions of aldosterone: From receptors and signals to membrane targets
Dooley, R., Harvey, B. J., & Thomas, W. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.019 · Cited by 120
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
Tesch, G. H., & Young, M. J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00313 · Cited by 112
Bioactive Candy: Effects of Licorice on the Cardiovascular System
Deutch, M. R., Grimm, D., Wehland, M., Infanger, M., & Krüger, M. (2019) · Foods · doi:10.3390/foods8100495 · Cited by 98
Corticosteroid receptors, macrophages and cardiovascular disease
Rickard, A. J., & Young, M. J. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0144 · Cited by 105
Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury
Ma, J., Weisberg, A. D., Griffin, J. P., Vaughan, D. E., Fogo, A. B., & Brown, N. J. (2006) · Kidney International · doi:10.1038/sj.ki.5000201 · Cited by 96
Kristanc, L., & Kreft, S. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.04.007 · Cited by 92
Jain, R., Hussein, M. A., Pierce, S., Martens, C., Shahagadkar, P., & Munirathinam, G. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106138 · Cited by 94
Queisser, N., & Schupp, N. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.011 · Cited by 79
Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology
Cannavò, A., Bencivenga, L., Liccardo, D., Elia, A., Marzano, F., Gambino, G., D’Amico, M. L., Perna, C., Ferrara, N., Rengo, G., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1204598 · Cited by 79
Treatment of polycystic ovary syndrome with spironolactone plus licorice
Armanini, D., Castello, R., Scaroni, C. M., Bonanni, G., Faccini, G., Pellati, D., Bertoldo, A., Fiore, C., & Moghetti, P. (2006) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.10.013 · Cited by 75
Self-citationMechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis
Young, M. J., & Rickard, A. J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.008 · Cited by 73
Licorice: From Pseudohyperaldosteronism to Therapeutic Uses
Sabbadin, C., Bordin, L., Donà, G., Manso, J., Avruscio, G., & Armanini, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00484 · Cited by 72
Self-citationThe Mineralocorticoid Receptor and Oxidative Stress
Fiebeler, A., & Luft, F. C. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-2348-y · Cited by 62
Feraco, A., Armani, A., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.012 · Cited by 58
Aldosterone activates endothelial exocytosis
Jeong, Y., Chaupin, D. F., Matsushita, K., Yamakuchi, M., Cameron, S. J., Morrell, C. N., & Lowenstein, C. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804037106 · Cited by 56
Dean, M., Murphy, B. T., & Burdette, J. E. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.013 · Cited by 59
Lastra, G., & Sowers, J. R. (2013) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0025 · Cited by 55
Spironolactone in the treatment of polycystic ovary syndrome
Armanini, D., Andrisani, A., Bordin, L., & Sabbadin, C. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1215430 · Cited by 53
Self-citationAldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes
Chun, T.-Y., & Pratt, J. H. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.03.016 · Cited by 52
Aldosterone Impairs Bone Marrow–Derived Progenitor Cell Formation
Marumo, T., Uchimura, H., Hayashi, M., Hishikawa, K., & Fujita, T. (2006) · Hypertension · doi:10.1161/01.hyp.0000235681.25685.cf · Cited by 52
Why are mineralocorticoid receptor antagonists cardioprotective?
Chai, W., & Danser, A. H. J. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0107-9 · Cited by 51
Sharma, R., Singla, R. K., Banerjee, S., & Sharma, R. (2023) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105452 · Cited by 45
Shah, S. L., Wahid, F., Khan, N., Farooq, U., Shah, A. J., Tareen, S., Ahmad, F., & Khan, T. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/8438101 · Cited by 48
Lim, T. K. (2016) · Springer eBooks · doi:10.1007/978-94-017-7276-1_18 · Cited by 47
Sarafidis, P. A., Iatridi, F., Ferro, C. J., Alexandrou, M. E., Fernández‐Fernández, B., Kanbay, M., Mallamaci, F., Nistor, I., Rossignol, P., Wanner, C., et al. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad139 · Cited by 47
Aldosterone receptor blockers spironolactone and canrenone: Two multivalent drugs
Armanini, D., Sabbadin, C., Donà, G., Clari, G., & Bordin, L. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.896901 · Cited by 41
Self-citationSalvi, M., Fiore, C., Battaglia, V., Palermo, M., Armanini, D., & Toninello, A. (2005) · Endocrinology · doi:10.1210/en.2004-1128 · Cited by 39
Self-citationIn Vitro and in Vivo Inhibitory Effects of Glycyrrhetinic Acid in Mice and Human Cytochrome P450 3A4
Lv, Q.-L., Wang, G., Chen, S.-H., Hu, L., Zhang, X., Ying, G., Qin, C.-Z., & Zhou, H.-H. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13010084 · Cited by 35
Bergmann, A., Eulenberg-Gustavus, C., Wellner, M., Rolle, S., Luft, F. C., & Kettritz, R. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.141309 · Cited by 35
Park, Y. M., Lim, B. H., Touyz, R. M., & Park, J. B. (2008) · Journal of Korean Medical Science · doi:10.3346/jkms.2008.23.6.1039 · Cited by 34
Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization
Barry, Z., Park, B., & Corson, T. W. (2020) · Molecules · doi:10.3390/molecules25153468 · Cited by 36
Ma, J., Albornoz, F., Yu, C., Byrne, D. W., Vaughan, D. E., & Brown, N. J. (2005) · Hypertension · doi:10.1161/01.hyp.0000174327.53863.86 · Cited by 33
Athimulam, S., Lazik, N., & Bancos, I. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.08.003 · Cited by 31
Syndromes that Mimic an Excess of Mineralocorticoids
Sabbadin, C., & Armanini, D. (2016) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-016-0160-5 · Cited by 26
Self-citationAldosterone in gynecology and its involvement on the risk of hypertension in pregnancy
Sabbadin, C., Andrisani, A., Ambrosini, G., Bordin, L., Donà, G., Manso, J., Ceccato, F., Scaroni, C., & Armanini, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00575 · Cited by 22
Self-citationCalò, L. A., Pagnin, E., Davis, P. A., Armanini, D., Mormino, P., Rossi, G. P., & Pessina, A. C. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346549 · Cited by 21
Self-citationGlycyrrhetinic acid as inhibitor or amplifier of permeability transition in rat heart mitochondria
Battaglia, V., Brunati, A. M., Fiore, C., Rossi, C. A., Salvi, M., Tibaldi, E. V., Palermo, M., Armanini, D., & Toninello, A. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.10.008 · Cited by 21
Self-citationVecchiola, A., Fuentes, C., Barros, E., Martínez‐Aguayo, A., García, H., Allende, F. A., Solari, S., Olmos, R. I., Carvajal, C. A., Tapia-Castillo, A., et al. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz023 · Cited by 20
Parker, J., O'Brien, C. L., Yeoh, C., Gersh, F. L., & Brennecke, S. P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061774 · Cited by 21
Armanini, D., Scaroni, C. M., Mattarello, M. J., Fiore, C., Albiger, N. M. E., & Sartorato, P. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345379 · Cited by 17
Self-citationArmanini, D., Andrisani, A., Donà, G., Bordin, L., Ambrosini, G., & Sabbadin, C. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13074 · Cited by 15
Self-citationArmanini, D., Sabbadin, C., Donà, G., Bordin, L., Marin, L., Andrisani, A., & Ambrosini, G. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13262 · Cited by 14
Self-citationKimura, H., Li, X., Torii, K., Okada, T., Kamiyama, K., Mikami, D., Takahashi, N., & Yoshida, H. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn756 · Cited by 15
Association of primary aldosteronism with chronic thyroiditis
Sabbadin, C., Mian, C., Nacamulli, D., Donà, G., Presotto, F., Betterle, C., Boscaro, M., Bordin, L., & Armanini, D. (2016) · Endocrine · doi:10.1007/s12020-016-0880-2 · Cited by 15
Self-citationFogari, R., Derosa, G., Zoppi, A., Lazzari, P., D’Angelo, A., & Mugellini, A. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.874415 · Cited by 14
Effect of glycyrrhetinic acid on membrane band 3 in human erythrocytes
Fiore, C., Bordin, L., Pellati, D., Armanini, D., & Clari, G. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.08.011 · Cited by 14
Self-citationRole of Renin-Angiotensin-Aldosterone System and Cortisol in Endometriosis: A Preliminary Report
Sabbadin, C., Saccardi, C., Andrisani, A., Vitagliano, A., Marin, L., Ragazzi, E., Bordin, L., Ambrosini, G., & Armanini, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010310 · Cited by 12
Self-citationRole of Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
Alexandrou, M. E., Theodorakopoulou, M. P., & Sarafidis, P. A. (2022) · Kidney and Dialysis · doi:10.3390/kidneydial2020019 · Cited by 12
Mineralocorticoid receptor is involved in the aldosterone pathway in human red blood cells.
Bordin, L., Saccardi, C., Donà, G., Sabbadin, C., Andrisani, A., Ambrosini, G., Plebani, M., Brunati, A. M., Ragazzi, E., Gizzo, S., et al. (2016) · PubMed Central · Cited by 12
Self-citationIdentification of the mineralocorticoid receptor in human spermatozoa
Fiore, C., Sticchi, D., Pellati, D., Forzan, S., Bonanni, G., Bertoldo, A., Massironi, M., Calò, L. A., Fassina, A., Rossi, G. P., et al. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.18.4.649 · Cited by 11
Self-citationAldosterone and Myocardial Pathology
Cannavò, A., Elia, A., Liccardo, D., Rengo, G., & Koch, W. J. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.09.005 · Cited by 11
This is not Dr. Conn's aldosterone anymore.
Brown, N. J. (2011) · PubMed Central · Cited by 10
Armanini, D., Andrisani, A., Ambrosini, G., Donà, G., Camozzi, V., Bordin, L., & Sabbadin, C. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12822 · Cited by 10
Self-citationLicorice-induced hypertension: a case of pseudohyperaldosteronism due to jelly bean ingestion
Foster, C., Church, K. S., Poddar, M., Uum, S. V. V., & Spaic, T. (2017) · Postgraduate medicine · doi:10.1080/00325481.2017.1291062 · Cited by 11
Glycyrrhizic Acid Inhibits High-Mobility Group Box-1 and Homocysteine-Induced Vascular Dysfunction
Gadanec, L. K., Andersson, J., Apostolopoulos, V., & Zulli, A. (2023) · Nutrients · doi:10.3390/nu15143186 · Cited by 9
Brown, N. J., Muldowney, J. A. S., & Vaughan, D. E. (2006) · Hypertension · doi:10.1161/01.hyp.0000202478.79587.1a · Cited by 9
Microalbuminuria and Hypertension in Pregnancy: Role of Aldosterone and Inflammation
Armanini, D., Ambrosini, G., Sabbadin, C., Donà, G., Clari, G., & Bordin, L. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12135 · Cited by 7
Self-citationThe cardiovascular complications of licorice
Omar, H. R. (2013) · Cardiovascular Endocrinology · doi:10.1097/xce.0b013e328362e3dd · Cited by 7
Torsade de Pointes Caused by a Compound Licorice Tablet
Zhang, Y., Yang, J., & Xie, J. (2024) · International Heart Journal · doi:10.1536/ihj.23-609 · Cited by 7
Choice of Diuretic Therapy and Reconsideration for Aldosterone Receptors Blockers
Armanini, D., & Fiore, C. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.147074 · Cited by 7
Self-citationSome considerations about evolution of idiopathic primary aldosteronism
Armanini, D., & Fiore, C. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346520 · Cited by 7
Self-citationManso, J., Pedron, M. C., Mondin, A., Censi, S., Pennelli, G., Galuppini, F., Barollo, S., Bertazza, L., Radu, C. M., Ghini, F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020754 · Cited by 6
Self-citationWu, F., Yun, L., & Liu, Q. (2018) · Endocrine · doi:10.1007/s12020-018-1610-8 · Cited by 6
Heanue, S., Kanki, M., Morgan, J., Ng, J., Cole, T. J., Lancaster, G. I., Ray, D. W., & Young, M. J. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00415.2024 · Cited by 7
Low Cortisone as a Novel Predictor of the Low-Renin Phenotype
Tapia-Castillo, A., Carvajal, C. A., Pérez, J. A., Sandoval, A., Allende, F. A., Solari, S., & Fardella, C. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae051 · Cited by 5
Taming the Fire of Nephrotoxic Botanicals
Holden, F., Amin, V., Kuek, D., Kopp, J. B., Hendry, B. M., & Xu, Q. (2019) · World Journal of Traditional Chinese Medicine · doi:10.4103/wjtcm.wjtcm_2_19 · Cited by 5
Aldosterone and end-organ damage
Brown, N. J. (2005) · Current Opinion in Internal Medicine · doi:10.1097/00132980-200508000-00009 · Cited by 5
Fiore, C., Sartorato, P., Pagnin, E., Ragazzi, E., Calò, L. A., & Armanini, D. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345768 · Cited by 5
Self-citationArmanini, D. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.193011 · Cited by 5
Self-citationAldosterone, Inflammation, and Preeclampsia
Armanini, D., & Calò, L. A. (2005) · Hypertension · doi:10.1161/01.hyp.0000157170.94539.ee · Cited by 5
Self-citationMononuclear Leukocyte Mineralocorticoid Receptors
Armanini, D., Fiore, C., & Calò, L. A. (2005) · Hypertension · doi:10.1161/01.hyp.0000197933.23193.31 · Cited by 5
Self-citationFreitas, F. E. D. A., Batista, M. A. C., Braga, D. C. D. A., de Oliveira, L. B., Antunes, V. R., & Cardoso, L. M. (2022) · Appetite · doi:10.1016/j.appet.2022.106050 · Cited by 4
Huo, M., Liu, H., Chen, S., Xiu, L., Yu, X. L., & Zhong, G. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1557717 · Cited by 4
Alexandrou, M. E., Theodorakopoulou, M. P., Kanbay, M., & Sarafidis, P. A. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-021-00641-1 · Cited by 4
Ravarotto, V., Simioni, F., Sabbadin, C., Pagnin, E., Maiolino, G., Armanini, D., & Calò, L. A. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0942-9 · Cited by 4
Self-citationAldosterone and thrombosis formation: Implications for ischemic and atherosclerotic heart disease
Calò, L. A., & Armanini, D. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344170 · Cited by 4
Self-citationEnigma of the Origin of Primary Aldosteronism
Armanini, D., Sabbadin, C., & Bordin, L. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13302 · Cited by 4
Self-citationArmanini, D., Sabbadin, C., Andrisani, A., Ambrosini, G., & Bordin, L. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13964 · Cited by 3
Self-citationRole of adrenocorticotropic hormone in essential hypertension and primary aldosteronism
Armanini, D., Andrisani, A., Ambrosini, G., Bordin, L., & Sabbadin, C. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12951 · Cited by 3
Self-citationNagelkirk, P. R., Franklin, B. A., Coughlin, A. M., Hassouna, H. I., Fink, G. D., Pivarnik, J. M., & Womack, C. J. (2007) · Preventive Cardiology · doi:10.1111/j.1520-037x.2007.06425.x · Cited by 3
Primary aldosteronism and resistant arterial hypertension
Звартау, Н. Э., Коростовцева, Л. С., Emelyanov, I. V., & Sviryaev, Y. V. (2012) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2012-18-6-514-521 · Cited by 2
Rustamzadeh, A., Zamani, S., Heidarian, E., Ahmadi, R., Rahimi‐Madiseh, M., & Nouri, A. (2023) · Comparative Clinical Pathology · doi:10.1007/s00580-023-03473-2 · Cited by 2
Yagi, S., & Sata, M. (2011) · European Heart Journal Supplements · doi:10.1093/eurheartj/sur012 · Cited by 2
Some Considerations About Primary Aldosteronism and Its Follow‐Up
Armanini, D., Sabbadin, C., Andrisani, A., Ambrosini, G., & Bordin, L. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12911 · Cited by 2
Self-citationArmanini, D., Andrisani, A., Ambrosini, G., Donà, G., Bordin, L., & Sabbadin, C. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13538 · Cited by 2
Self-citationArmanini, D., Sabbadin, C., & Boscaro, M. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01500-z · Cited by 2
Self-citationArmanini, D., Calò, L. A., & Fiore, C. (2011) · Kidney International · doi:10.1038/ki.2011.362 · Cited by 2
Self-citationAldosterone-mediated endothelial remodeling and oxidative stress
Calò, L. A., & Armanini, D. (2005) · Kidney International · doi:10.1038/ki.2005.4496300 · Cited by 2
Self-citation
Metadata
- Authors
- Calò, L. A., Zaghetto, F., Pagnin, E., Davis, P. A., de Mozzi, P., Sartorato, P., Martire, G., Fiore, C., & Armanini, D.
- Affiliations
- Department of Clinical and Experimental Medicine, Clinica Medica 4 (L.A.C., F.Z., E.P., P.D.M.), University of Padua, Padua 35100, Italy;
- University of Padua (IT)
- University of California, Davis (US)
- Corresponding author
- Armanini, Decio
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-04-01
- Volume
- 89
- Issue
- 4
- Pages
- 1973-1976
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1996601414
- Cited by
- 122
- References
- 0
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 4 · 2022: 8 · 2021: 2 · 2020: 4 · 2019: 9 · 2018: 9 · 2017: 4 · 2016: 11 · 2015: 1 · 2014: 4 · 2013: 6 · 2012: 4
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Effects of Natural Compounds
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- aldosterone, glycyrrhetinic acid, plasminogen activator inhibitor-1, p22phox, mononuclear leukocytes, mineralocorticoid receptor, oxidative stress, hyperaldosteronism, canrenone, licorice, fibrosis
- MeSH terms
- Adult, Aldosterone, Mineralocorticoid Receptor Antagonists, Canrenone, Dose-Response Relationship, Drug, Drug Synergism, Female, Glycyrrhetinic Acid, Humans, Leukocytes, Mononuclear, Male, NADPH Dehydrogenase, Phosphoproteins, Plasminogen Activator Inhibitor 1, NADPH Oxidases, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
